Alector, Inc. (ALEC)
1.975
+0.14
(+7.34%)
USD |
NASDAQ |
Oct 19, 15:49
Alector Net Income (Quarterly) : -22.99M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.99M |
| March 31, 2026 | -22.93M |
| December 31, 2025 | -37.27M |
| September 30, 2025 | -34.67M |
| June 30, 2025 | -30.52M |
| March 31, 2025 | -40.47M |
| December 31, 2024 | -2.074M |
| September 30, 2024 | -42.22M |
| June 30, 2024 | -38.68M |
| March 31, 2024 | -36.08M |
| December 31, 2023 | -41.43M |
| September 30, 2023 | -44.48M |
| June 30, 2023 | 1.375M |
| March 31, 2023 | -45.86M |
| December 31, 2022 | -52.43M |
| September 30, 2022 | -46.15M |
| June 30, 2022 | 9.883M |
| Date | Value |
|---|---|
| March 31, 2022 | -44.62M |
| December 31, 2021 | -55.61M |
| September 30, 2021 | 126.60M |
| June 30, 2021 | -55.15M |
| March 31, 2021 | -52.17M |
| December 31, 2020 | -52.18M |
| September 30, 2020 | -52.70M |
| June 30, 2020 | -45.33M |
| March 31, 2020 | -40.02M |
| December 31, 2019 | -30.53M |
| September 30, 2019 | -31.74M |
| June 30, 2019 | -24.56M |
| March 31, 2019 | -18.56M |
| December 31, 2018 | -17.37M |
| June 30, 2018 | -11.12M |
| March 31, 2018 | -8.437M |
| December 31, 2017 | -9.778M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.32M |
| Total Expenses (Quarterly) | 26.31M |
| EPS Diluted (Quarterly) | -0.2067 |
| Enterprise Value | 65.41M |
| Gross Profit Margin (Quarterly) | 38.28% |
| Profit Margin (Quarterly) | -692.5% |
| Earnings Yield | -55.30% |
| Normalized Earnings Yield | -52.81 |